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To understand the normal function of the prion 
protein (PrP) and its role in prion disorders, several 
groups have generated mice lacking PrP. Some of 
these mice develop symptoms associated with prion 
diseases, but other experimental evidence suggests 
that the loss of functional PrP is not the instigating 
factor in these disorders. 
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Human prion diseases are rare neurodegenerative disor- 
ders with genetic, sporadic or infectious etiologies 
(reviewed in [l]). The initial clinical presentation of 
affected individuals can vary from ataxia to dementia, with 
brain pathology dominated by spongiform degeneration 
and gliosis. A fraction of cases also show ‘amyloid’ plaques 
that are birefringent when stained with Congo Red, and 
immunoreactive with antiserum raised against the host- 
encoded prion protein (PrP). Creutzfeldt-Jakob disease 
(CJD) is the most common form of sporadic prion disor- 
ders, but familial forms of CJD have also been described. 
Gerstmann-Straussler-Scheinker disease (GSS) and fatal 
familial insomnia are other examples of familial prion dis- 
orders, and kuru is an example of a transmitted prion 
disease. Familial CJD and GSS are the only inherited 
human diseases in which nervous tissues from affected 
individuals can transmit disease to nonhuman primates 
and rodents. Prion disorders also are endemic to domestic 
sheep (scrapie), and more recently have become prevalent 
in cattle in the United Kingdom (bovine spongiform 
encephalopathy (BSE)). 
The ease of transmissibility of prions led to the establish- 
ment of the first rodent models of human neurodegenera- 
tive disease, and these models have greatly facilitated 
investigations of the underlying molecular mechanisms of 
disease. In both humans and other animals a critical event 
in the pathogenesis of prion diseases is the conversion of 
the normal cellular prion protein (PrPc), to an infectious 
form, termed scrapie prion protein (PrPsc) [2,3]. Although 
the mechanisms by which PrPC is converted to PrPSC are 
not fully defined, several lines of evidence indicate that 
PrPSC is generated from PrPC via alterations of protein con- 
formation [4-61. Despite the advances in our understand- 
ing of the cell biological and biochemical events involved 
in the conversion of PrPC to PrPSc, the function of PrPC 
and the role of PrPC in scrapie propagation has, until 
recently, been enigmatic and controversial. Several groups 
have approached these issues by generating mice in which 
the mouse prion protein gene was modified using gene-tar- 
geting strategies; here, we provide some perspectives on 
the lessons learned from these approaches. 
PrPC is required for infection with PrPSC 
Elegant studies by Biieler et al [7] convincingly demon- 
strated that mice devoid of PrPC (PrP”io or PrP knockout 
mice) do not succumb to prion infection when inoculated 
with mouse PrPSC, and do not support the clandestine 
replication of prions. These data firmly established that 
the host susceptibility to scrapie infection and prion prop- 
agation require the expression of PrPC. In these studies, 
PrP”/O mice developed normally up to the age of two years 
and did not exhibit behavioral abnormalities or neurologi- 
cal impairments [7]. These data supported the idea that 
PrPC is not critical either for normal development or for 
central nervous system function. Collinge et al. [8] repor- 
ted, however, that PrP”‘O mice exhibit neurophysiological 
defects in synaptic inhibition and long term potentiation, 
and that these defects in synaptic function could be 
rescued following cross-breeding to transgenic mice 
expressing human PrP [9]. Although these studies strongly 
suggested that the observed abnormalities in PrP”/O mice 
were the result of the loss of normal PrPC, a recent report 
demonstrated that the same PrP”lo animals do not exhibit 
defective synaptic physiology [lo]. The discrepancies in 
phenotypes may be explained by the fact that the original 
knockout animals were generated in hybrids of C57BL/6J 
and 129/Sv mouse strains. Reassortment of alleles during 
subsequent matings would then lead to the generation of 
sublines of mice that respond differently to diminished 
PrPC expression. 
PrP knockout mice can develop symptoms of prion 
diseases 
Recently, two groups independently reported on the 
generation of mouse strains devoid of PrPC [11,12] (see 
Fig. l), which exhibited striking behavioral and neu- 
ropathological alterations. Sakaguchi et al [ 1 Z] reported 
that mice with a targeted deletion of the entire open 
reading frame of the PrP gene lose Purkinje cells and 
exhibit ataxia and deficits in coordination at -70 weeks 
of age. In contrast, mice with insertionally disrupted PrP 
genes showed altered circadian rhythms and distur- 
bances in sleep patterns [13]. Notably, these latter mice 
were generated in Fl hybrids of 129/01a and F2 
(C57B1/6J x CBA) [ 111. 
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Schematic representation of two different methods for generating 
knockout mice by homologous recombination between cellular DNA 
and recombinant DNA. (a) Insertional disruption (used by Manson et al. 
[l II), (b) targeted deletion (used by Sakaguchi ef a/. [12]). Genomic 
sequences are shown at the top, with sequences contained in plasmid 
DNA shown below. Arrows indicate potential sites of recombination. 
Gray, genomic DNA; magenta, target gene; blue, foreign DNA; black 
line, plasmid vector DNA. X and Y are used to indicate regions of 
identical genomic DNA. The cell lines generated by these techniques 
are heterozygous for the PrP mutation. Mice are produced by injection 
of the engineered cells into a host blastocyst and are interbred to 
produce offspring that are homozygous for the mutation. 
Interpreting the phenotypes of the knockout mice 
Can we relate the phenotypes of the PrP knockout mice to 
the clinical manifestations of human prion disorders? In 
view of the varied phenotypes associated with one or more 
of the human prion disorders including diminished synap- 
tic function, ataxia, and altered sleep patterns, it is tempt- 
ing to speculate that the loss of functional PrPc (as a result 
of conversion to PrPSc) causes the clinical symptoms associ- 
ated with prion disorders. To address this issue, Brandner et 
al. [14] grafted normal murine brain tissue into the brains 
of PrP”io animals, and subsequently infected the graft with 
PrPSC. Surprisingly, neurodegenerative pathology was 
restricted to the graft, and surrounding tissues were spared 
despite the presence of PrPSC outside of the boundary of 
the graft. These data suggested that neurodegeneration is 
the result of deleterious events intrinsic to cells within the 
graft (which may, or may not, include the acute depletion 
of PrPC) and that PrPSC is not itself neurotoxic to neurons 
lacking PrPC. Although the graft studies offered the 
provocative suggestion that neurodegeneration in prion 
disorders might be the result of depletion of cellular pools 
of PrPC, several lines of experimental evidence argue 
against this notion. First, PrP”io mice do not exhibit pathol- 
ogy typical of prion disorders (gliosis, spongiform degener- 
ation). Second, although a hamster prion inoculum 
administered into transgenic mice expressing hamster 
PrPC provokes spongiform degeneration in the host, the 
only PrPC converted to PrPSC is of hamster origin, suggest- 
ing that the cellular pool of mouse PrPC is unaltered 
[15,16]. Third, forced overexpression of PrPC in transgenic 
animals results not in a delay, but rather in the acceleration, 
of disease onset following inoculation with prions [l&16]. 
Finally, the presence of high levels of overexpressed PrPC 
in transgenic mice leads to spontaneous prion disease [ 171. 
Taken together, little biochemical and genetic evidence 
has accrued that lends support to the notion that depletion 
of PrPC contributes to pathogenesis of prion disease. 
The disparate phenotypes between the PrP knockout 
mice generated by three different groups underscores 
the complexities involved in modeling human diseases in 
transgenic or knockout mice. The knockout mice were 
generated from hybrid mouse strains with genetically 
heterogeneous backgrounds, and subsequently interbred 
to generate mice homozygous for the deleted allele; thus, 
the genotype of each inbred line will be significantly dif- 
ferent. Heterogeneity in genetic background between 
lines of knockout mice may translate into differing phe- 
notypes due to changes in the levels of expression of 
molecules that compensate functionally for the missing 
protein, or molecules that transduce or modify functional 
information. In support of this view, there are profoundly 
different phenotypes among various inbred strains of 
mice with a particular disruption of the gene encoding 
the transcription factor Hoxb-4 [18]. In addition, each of 
the PrP knockout lines were generated using different 
targeting strategies, and hence subtle differences in 
expression of the remaining PrPC coding regions in tar- 
geted genes or genes located near (or within) the PrP 
gene may be responsible for the phenotypic heterogene- 
ity. It is relevant to note that mice with an insertionally 
inactivated exon of the cystic fibrosis transmembrane 
regulator gene [19] exhibited a phenotype remarkably 
different to that of mice in which the identical exon was 
replaced with foreign sequences [ZO]. To address the 
influences of genetic heterogeneity and genomic manip- 
ulations, it will be necessary to prove that the observed 
phenotype(s) can be rescued by the expression of PrP 
cDNA transgenes. 
Conclusions and future directions 
Although the phenotypes of PrP”io mice may mimic a 
subset of the clinical features of human prion disorders, the 
weight of evidence suggests that loss of functional PrPC is 
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not the instigating factor in disease. Moreover, the normal 
function of PrPC remains a mystery and attempts to clarify 
(1993). Hoxb-4 (Hex-2.6) mutant mice show homeotic transformation 
of a cervical vertebra and defects in the closure of the sternal 
rudiments. Cell 73, 279-294. 
this issue using knockout strategies have been confounded 19. Snouwaert, J.N., et a/,, & Keller, B.H. (1992). An animal model for 
by the complexities of mouse genetics and gene-targeting cystic fibrosis made by gene targeting. Science 257, 1083-l 088. 
strategies. With these caveats in mind, we believe that it is 
20. Dorin, J.R., et a/., & Porteous, D.J. (1992). Cystic fibrosis in the mouse 
by targeted insertional mutagenesis. Nature 359, 21 l-21 5. 
essential to generate highly inbred (congenic) mouse 
strains with disrupted PTP genes to fully appreciate the 
consequences of loss of normal PrPC. These genetic 
approaches will greatly facilitate the identification of host 
gene products that modify the phenotypes of PrP”io mice, 
efforts that will no doubt provide insights into the normal 
biology of PrPC and its role in the pathophysiology of the 
enigmatic spongiform encephalomyopathies. 
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